TY - JOUR AU - Ferlay, J. PY - 2015 DA - 2015// TI - Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 JO - Int J Cancer. VL - 136 UR - https://doi.org/10.1002/ijc.29210 DO - 10.1002/ijc.29210 ID - Ferlay2015 ER - TY - JOUR AU - Ma, J. PY - 2017 DA - 2017// TI - BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma JO - Cancer Lett. VL - 411 UR - https://doi.org/10.1016/j.canlet.2017.09.041 DO - 10.1016/j.canlet.2017.09.041 ID - Ma2017 ER - TY - JOUR AU - Johnstone, T. C. AU - Suntharalingam, K. AU - Lippard, S. J. PY - 2016 DA - 2016// TI - The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs JO - Chemical reviews VL - 116 UR - https://doi.org/10.1021/acs.chemrev.5b00597 DO - 10.1021/acs.chemrev.5b00597 ID - Johnstone2016 ER - TY - JOUR AU - Woynarowski, J. M. PY - 2000 DA - 2000// TI - Oxaliplatin-induced damage of cellular DNA JO - Mol Pharmac. VL - 58 UR - https://doi.org/10.1124/mol.58.5.920 DO - 10.1124/mol.58.5.920 ID - Woynarowski2000 ER - TY - BOOK AU - Eva Martinez-Balibrea, A. M. A. G. AU - Catia Moutinho, L. L. J. L. AU - Manel Esteller, A. A. A. PY - 2015 DA - 2015// TI - Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance UR - https://doi.org/10.1158/1535-7163.MCT-14-0636 DO - 10.1158/1535-7163.MCT-14-0636 ID - Eva Martinez-Balibrea2015 ER - TY - JOUR AU - Su, X. PY - 2015 DA - 2015// TI - An In Vivo Method to Identify microRNA Targets Not Predicted by Computation Algorithms: p21 Targeting by miR-92a in Cancer JO - Cancer Res. VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2218 DO - 10.1158/0008-5472.CAN-14-2218 ID - Su2015 ER - TY - STD TI - E Callegari, L.G.M.D., MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death and Differentiation. 2015, 1350-9047/15. ID - ref7 ER - TY - JOUR AU - Wei Wang, Y. W. W. L. PY - 2017 DA - 2017// TI - Regulation and biological roles of the multifaceted miRNA-23b (MIR23B) JO - GENE VL - S0378-1119 ID - Wei Wang2017 ER - TY - STD TI - X Qiu, S.D.F.Q., HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene,2013 (0950-9232/13). ID - ref9 ER - TY - STD TI - Timothy R. Wagenaar SZ. Anti–miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation. Mol Cell Biomech. 2015;13(6):1009–21. https://doi.org/10.1158/1541-7786. ID - ref10 ER - TY - BOOK AU - Alina Simerzin, E. Z. K. PY - 2016 DA - 2016// TI - The liver-specific miR-122*,the complementary strand of miR-122, acts as a tumor suppressor by modulating the p53-Mdm2 circuitry, Hepatology ID - Alina Simerzin2016 ER - TY - STD TI - Hyung Seok Kim KSL. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget. 2015;6(10):8089–102. ID - ref12 ER - TY - JOUR AU - Di Leva, G. AU - Garofalo, M. AU - Croce, C. M. PY - 2014 DA - 2014// TI - MicroRNAs in cancer JO - Annu Rev Pathol. VL - 9 UR - https://doi.org/10.1146/annurev-pathol-012513-104715 DO - 10.1146/annurev-pathol-012513-104715 ID - Di Leva2014 ER - TY - STD TI - Andreas Karakatsanis, I.P.M.G. and A.D.V. George Polymeneas, Expression of MicroRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c,miR-221, miR-222, and miR-223 in Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma and its Prognostic Significance. MOLECULAR CARCINOGENESIS. 2011. https://doi.org/10.1002/mc.21864. ID - ref14 ER - TY - JOUR AU - Kim, H. S. PY - 2015 DA - 2015// TI - MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9 JO - cancer lettes VL - 6 ID - Kim2015 ER - TY - STD TI - Bartek, S.P.J.J., The DNA damage response in human biology and disease. Nature.2009. Vol 461j22 October 2009j https://doi.org/10.1038/nature08467. ID - ref16 ER - TY - STD TI - Christina M. Annunziata And Joyce O Shaughnessy, PARP as a novel therapeutic target in cancer. Clin Cancer Res.2010. Sep 15; 16(18): 4517–4526. ID - ref17 ER - TY - JOUR AU - Clark, C. C. AU - Weitzel, J. N. AU - O'Connor, T. R. PY - 2012 DA - 2012// TI - Enhancement of Synthetic Lethality via Combinations of ABT-888, a PARP Inhibitor, and Carboplatin In Vitro and In Vivo Using BRCA1 and BRCA2 Isogenic Models JO - Molecular Cancer Therapeutics VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0597 DO - 10.1158/1535-7163.MCT-11-0597 ID - Clark2012 ER - TY - STD TI - Miau-Rong Lee, C.L.C.L. and F.L.J.Y. Hong-Yi Chiu, YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells. BioMedicine. 2017. June 2017, Vol.7, No.2, Article 5, Pages 31-42. ID - ref19 ER - TY - JOUR AU - Hannah, L. AU - Moody, M. J. L. A. PY - 2017 DA - 2017// TI - MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma JO - Mol Ther Nucleic Acids. VL - 8 UR - https://doi.org/10.1016/j.omtn.2017.07.001 DO - 10.1016/j.omtn.2017.07.001 ID - Hannah2017 ER - TY - STD TI - Xu, W., Chen, Q., Wang, Q. JWA reverses cisplatin resistance2 via the CK2—XRCC1 pathway in human gastric cancer cells. Cell Death and Disease 2014. 2041-4889/14 ID - ref21 ER - TY - STD TI - Zhuo Dong A, Z.Z.A.L., MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Letters. 2013. 10.1016/j.canlet.2013.09.034 ID - ref22 ER - TY - JOUR AU - Wu, G. AU - Zheng, K. PY - 2016 DA - 2016// TI - MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma JO - Journal of Experimental & Clinical Cancer Research VL - 35 UR - https://doi.org/10.1186/s13046-016-0368-1 DO - 10.1186/s13046-016-0368-1 ID - Wu2016 ER - TY - STD TI - CHUAN TIAN, S.Y.L.L. and Y.G.N.Y. XIAO DONG, Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2017. https://doi.org/10.3892/ijmm.2016.2812 ID - ref24 ER - TY - JOUR AU - Zhang, L. AU - Xiang, Z. L. AU - Zeng, Z. C. PY - 2016 DA - 2016// TI - A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma JO - Oncotarget. VL - 7 ID - Zhang2016 ER - TY - JOUR AU - Yin, F. AU - Shu, L. PY - 2016 DA - 2016// TI - Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma JO - Journal of Experimental & Clinical Cancer Research VL - 35 UR - https://doi.org/10.1186/s13046-016-0403-2 DO - 10.1186/s13046-016-0403-2 ID - Yin2016 ER - TY - JOUR AU - Yu, L. AU - Sun, Y. AU - Li, J. PY - 2017 DA - 2017// TI - Silencing the Girdin gene enhances radiosensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism JO - Journal of Experimental & Clinical Cancer Research VL - 36 UR - https://doi.org/10.1186/s13046-017-0580-7 DO - 10.1186/s13046-017-0580-7 ID - Yu2017 ER - TY - JOUR AU - Yi, W. AU - Chen, K. PY - 2017 DA - 2017// TI - et.al. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma JO - Journal of Experimental & Clinical Cancer Research VL - 36 UR - https://doi.org/10.1186/s13046-017-0581-6 DO - 10.1186/s13046-017-0581-6 ID - Yi2017 ER - TY - JOUR AU - Stewart, D. J. PY - 2007 DA - 2007// TI - Mechanisms of resistance to cisplatin and carboplatin JO - Oncology/Hematology VL - 2007 UR - https://doi.org/10.1016/j.critrevonc.2007.02.001 DO - 10.1016/j.critrevonc.2007.02.001 ID - Stewart2007 ER - TY - STD TI - Henna V. Kuusisto, Jans, D. A., Hyper-dependence of breast cancer cell types on the nuclear transporter Importin β1. Biochimica et Biophysica Acta .2015.1853 (2015) 1870–1878 ID - ref30 ER - TY - STD TI - Z. Ouar, R. Lacave, M. Bens Mechanisms of altered sequestration and e¥ux of chemotherapeutic drugs by multidrug-resistant cells. Cell Biology and Toxicology. 1999; 15: 91^100 ID - ref31 ER - TY - JOUR AU - Boac, B. M. PY - 2016 DA - 2016// TI - Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance JO - Gynecol Oncol VL - 140 UR - https://doi.org/10.1016/j.ygyno.2015.12.026 DO - 10.1016/j.ygyno.2015.12.026 ID - Boac2016 ER - TY - JOUR AU - Pennati, M. PY - 2014 DA - 2014// TI - miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells JO - Biochem Pharmacol VL - 87 UR - https://doi.org/10.1016/j.bcp.2013.12.009 DO - 10.1016/j.bcp.2013.12.009 ID - Pennati2014 ER - TY - JOUR AU - Dehghanzadeh, R. PY - 2015 DA - 2015// TI - MicroRNA-induced drug resistance in gastric cancer JO - Biomed Pharmacother VL - 74 UR - https://doi.org/10.1016/j.biopha.2015.08.009 DO - 10.1016/j.biopha.2015.08.009 ID - Dehghanzadeh2015 ER -